Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
GILLIGAN, JAMES
and
LEE, BANDY
2004.
The Psychopharmacologic Treatment of Violent Youth.
Annals of the New York Academy of Sciences,
Vol. 1036,
Issue. 1,
p.
356.
Prisinzano, Thomas
Podobinski, John
Tidgewell, Kevin
Luo, Min
and
Swenson, Dale
2004.
Synthesis and determination of the absolute configuration of the enantiomers of modafinil.
Tetrahedron: Asymmetry,
Vol. 15,
Issue. 6,
p.
1053.
Campbell Daley, Katie
2004.
Update on attention-deficit/hyperactivity disorder.
Current Opinion in Pediatrics,
Vol. 16,
Issue. 2,
p.
217.
Le Heuzey, M.-F
2004.
Les traitements médicaux de l’enfant hyperactif.
Archives de Pédiatrie,
Vol. 11,
Issue. 1,
p.
64.
Kratochvil, Christopher J
Vaughan, Brigette S
Daughton, Joan M
Mayfield-Jorgensen, Michelle L
and
Burke, William J
2004.
Atomoxetine in the treatment of attention deficit hyperactivity disorder.
Expert Review of Neurotherapeutics,
Vol. 4,
Issue. 4,
p.
601.
Osorio-Lozada, Antonio
Prisinzano, Thomas
and
Olivo, Horacio F.
2004.
Synthesis and determination of the absolute stereochemistry of the enantiomers of adrafinil and modafinil.
Tetrahedron: Asymmetry,
Vol. 15,
Issue. 23,
p.
3811.
Hazell, Philip
2005.
Do adrenergically active drugs have a role in the first-line treatment of attention-deficit/hyperactivity disorder?.
Expert Opinion on Pharmacotherapy,
Vol. 6,
Issue. 12,
p.
1989.
Brunt, David L. Van
Johnston, Joseph A.
Ye, Wenyu
Pohl, Gerhardt M.
Sun, Pei J.
Sterling, Kimberly L.
and
Davis, Martha E.
2005.
Predictors of Selecting Atomoxetine Therapy for Children with Attention-Deficit–Hyperactivity Disorder.
Pharmacotherapy,
Vol. 25,
Issue. 11,
p.
1541.
Toren, Paz
Rehavi, Moshe
Luski, Anat
Roz, Netta
Laor, Nathaniel
Lask, Michal
and
Weizman, Abraham
2005.
Decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder.
European Neuropsychopharmacology,
Vol. 15,
Issue. 2,
p.
159.
Spiller, Henry A.
Klein-Schwartz, Wendy
Colvin, Jonathan M.
Villalobos, Danny
Johnson, Paul B.
and
Anderson, Deborah L.
2005.
Toxic clonidine ingestion in children.
The Journal of Pediatrics,
Vol. 146,
Issue. 2,
p.
263.
Himpel, Sunke
Banaschewski, Tobias
Heise, Cord-Alexander
and
Rothenberger, Aribert
2005.
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
Expert Opinion on Drug Safety,
Vol. 4,
Issue. 2,
p.
311.
Abrams, Laura
Flood, Jillian
and
Phelps, LeAdelle
2006.
Psychopharmacology in the schools.
Psychology in the Schools,
Vol. 43,
Issue. 4,
p.
493.
Haffner, Johann
Roos, Jeanette
Goldstein, Nicole
Parzer, Peter
and
Resch, Franz
2006.
Zur Wirksamkeit körperorientierter Therapieverfahren bei der Behandlung hyperaktiver Störungen: Ergebnisse einer kontrollierten Pilotstudie.
Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie,
Vol. 34,
Issue. 1,
p.
37.
Staller, Jud
and
Faraone, Stephen V
2006.
Attention-Deficit Hyperactivity Disorder in Girls.
CNS Drugs,
Vol. 20,
Issue. 2,
p.
107.
Turner, Danielle
2006.
A review of the use of modafinil for attention-deficit hyperactivity disorder.
Expert Review of Neurotherapeutics,
Vol. 6,
Issue. 4,
p.
455.
Hermens, Daniel F
Rowe, Donald L
Gordon, Evian
and
Williams, Leanne M
2006.
Integrative neuroscience approach to predict ADHD stimulant response.
Expert Review of Neurotherapeutics,
Vol. 6,
Issue. 5,
p.
753.
Rains, Adrienne
and
Scahill, Lawrence
2006.
Psychopharmacology Notes. Nonstimulant Medications for the Treatment of ADHD.
Journal of Child and Adolescent Psychiatric Nursing,
Vol. 19,
Issue. 1,
p.
44.
Turgay, Atilla
2006.
Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder.
Therapy,
Vol. 3,
Issue. 1,
p.
19.
Madaan, Vishal
Kinnan, Shannon
Daughton, Joan
and
Kratochvil, Christopher J
2006.
Innovations and recent trends in the treatment of ADHD.
Expert Review of Neurotherapeutics,
Vol. 6,
Issue. 9,
p.
1375.
Turgay, Atilla
2006.
Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder.
Therapy,
Vol. 3,
Issue. 1,
p.
19.